ArticleBlood2010

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

Jaebok Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.